Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1965 1
1968 1
1969 1
1972 2
1973 4
1974 2
1975 30
1976 19
1977 13
1978 16
1979 28
1980 35
1981 40
1982 44
1983 62
1984 76
1985 93
1986 111
1987 102
1988 113
1989 166
1990 191
1991 253
1992 282
1993 355
1994 387
1995 446
1996 543
1997 598
1998 605
1999 708
2000 800
2001 895
2002 991
2003 1097
2004 1288
2005 1580
2006 1822
2007 2037
2008 2360
2009 2618
2010 2897
2011 3511
2012 3918
2013 4585
2014 5046
2015 5728
2016 6224
2017 6650
2018 7109
2019 7741
2020 9345
2021 10809
2022 11192
2023 10775
2024 10685
2025 49

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110,029 results

Results by year

Filters applied: . Clear all
Page 1
Baseline characteristics and treatment-emergent risk factors associated with cerebrovascular event and death with risperidone in dementia patients.
Howard R, Costafreda SG, Karcher K, Coppola D, Berlin JA, Hough D. Howard R, et al. Br J Psychiatry. 2016 Nov;209(5):378-384. doi: 10.1192/bjp.bp.115.177683. Epub 2016 Jul 7. Br J Psychiatry. 2016. PMID: 27388570 Review.
Little is known about individual patient characteristics that might be associated with bad or good outcomes. AIMS: We examined the risperidone clinical trial data to look for individual patient characteristics associated with these adverse outcomes. ...Interactions …
Little is known about individual patient characteristics that might be associated with bad or good outcomes. AIMS: We examined the ri …
NTP Research Report on Baseline Characteristics of Diversity Outbred (J:DO) Mice Relevant to Toxicology Studies: Research Report 6.
Harrill AH, Borghoff S, Zorrilla L, Blystone C, Kissling GE, Malarkey D, Shockley K, Travlos G, DeVito MJ. Harrill AH, et al. Durham (NC): National Toxicology Program; 2018 Jun. Durham (NC): National Toxicology Program; 2018 Jun. PMID: 30188648 Free Books & Documents. Review.
Genetic variability in humans is a key characteristic underlying susceptibility potential for responses to environmental chemicals, yet animal testing paradigms typically do not capture the breadth of human diversity. Diversity Outbred (J:DO) mice are a population of outbr …
Genetic variability in humans is a key characteristic underlying susceptibility potential for responses to environmental chemicals, y …
Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme.
Jackson DJ, Pelaia G, Emmanuel B, Tran TN, Cohen D, Shih VH, Shavit A, Arbetter D, Katial R, Rabe APJ, Garcia Gil E, Pardal M, Nuevo J, Watt M, Boarino S, Kayaniyil S, Chaves Loureiro C, Padilla-Galo A, Nair P. Jackson DJ, et al. Eur Respir J. 2024 Jul 11;64(1):2301521. doi: 10.1183/13993003.01521-2023. Print 2024 Jul. Eur Respir J. 2024. PMID: 38575162 Free PMC article.
Additional large-cohort data are needed to confirm its real-world effectiveness in SEA according to previous biologic use and key baseline characteristics important for treatment selection. METHODS: XALOC-1 is a large, multinational, retrospective, observational, re …
Additional large-cohort data are needed to confirm its real-world effectiveness in SEA according to previous biologic use and key baselin …
The influence of baseline characteristics on the efficacy of immune checkpoint inhibitors for advanced lung cancer: A systematic review and meta-analysis.
Xiao Q, Yu X, Shuai Z, Yao T, Yang X, Zhang Y. Xiao Q, et al. Front Pharmacol. 2022 Sep 9;13:956788. doi: 10.3389/fphar.2022.956788. eCollection 2022. Front Pharmacol. 2022. PMID: 36176428 Free PMC article.
Purpose: To investigate the impact of different baseline characteristics on the efficacy of immune checkpoint inhibitors (ICIs) for advanced lung cancer. ...To explore the potential interaction during the administration of ICI, patients were stratified by baselin …
Purpose: To investigate the impact of different baseline characteristics on the efficacy of immune checkpoint inhibitors (ICIs …
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics.
Jayne DRW, Terrier B, Hellmich B, Khoury P, Baylis L, Bentley JH, Steinfeld J, Yancey SW, Kwon N, Wechsler ME, Akuthota P. Jayne DRW, et al. ERJ Open Res. 2024 Jan 8;10(1):00509-2023. doi: 10.1183/23120541.00509-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38196889 Free PMC article.
The present analysis investigated the impact of baseline characteristics on clinical outcomes and characterised the OCS-sparing effect of mepolizumab. ...CONCLUSIONS: Mepolizumab treatment provided benefits to patients with EGPA across varying baseline clinic …
The present analysis investigated the impact of baseline characteristics on clinical outcomes and characterised the OCS-sparin …
Relevant baseline characteristics for describing patients with knee osteoarthritis: results from a Delphi survey.
Wildi LM, Hensel A, Wertli M, Michel BA, Steurer J. Wildi LM, et al. BMC Musculoskelet Disord. 2013 Dec 30;14:369. doi: 10.1186/1471-2474-14-369. BMC Musculoskelet Disord. 2013. PMID: 24373617 Free PMC article.
This Delphi survey aimed to generate a set of baseline characteristics for describing patients with knee osteoarthritis enrolled in clinical studies. ...Global knee pain was the only baseline characteristic that fulfilled among experts the predefined c …
This Delphi survey aimed to generate a set of baseline characteristics for describing patients with knee osteoarthritis enroll …
Baseline characteristics of the infant aphakia treatment study population: predicting recognition acuity at 4.5 years of age.
Hartmann EE, Lynn MJ, Lambert SR; Infant Aphakia Treatment Study Group. Hartmann EE, et al. Invest Ophthalmol Vis Sci. 2014 Dec 11;56(1):388-95. doi: 10.1167/iovs.14-15464. Invest Ophthalmol Vis Sci. 2014. PMID: 25503455 Free PMC article. Clinical Trial.
PURPOSE: To identify patient baseline characteristics that predict recognition acuity at 4.5 years of age in the Infant Aphakia Treatment Study, a study of patients with monocular infantile cataracts. METHODS: We analyzed baseline characteristics of th …
PURPOSE: To identify patient baseline characteristics that predict recognition acuity at 4.5 years of age in the Infant Aphaki …
Baseline echographic characteristics of tumors in eyes of patients enrolled in the Collaborative Ocular Melanoma Study: COMS report no. 29.
Collaborative Ocular Melanoma Study Group; Boldt HC, Byrne SF, Gilson MM, Finger PT, Green RL, Straatsma BR, Simpson ER, Hawkins BS. Collaborative Ocular Melanoma Study Group, et al. Ophthalmology. 2008 Aug;115(8):1390-7, 1397.e1-2. doi: 10.1016/j.ophtha.2007.12.015. Epub 2008 Feb 11. Ophthalmology. 2008. PMID: 18267342 Clinical Trial.
PURPOSE: To report baseline echographic characteristics of tumors in patients enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trials, to determine how often these characteristics matched prespecified criteria for choroidal melanoma, to e …
PURPOSE: To report baseline echographic characteristics of tumors in patients enrolled in the Collaborative Ocular Melanoma St …
Impact of Baseline Characteristics on Treatment Response to Intravitreal Aflibercept Injection for Wet Age-Related Macular Degeneration.
Ho AC, Saroj N, Baker K, Vitti R, Berliner AJ, Thompson D, Roth DB. Ho AC, et al. Ophthalmol Retina. 2018 Jul;2(7):676-683. doi: 10.1016/j.oret.2017.10.017. Epub 2017 Dec 27. Ophthalmol Retina. 2018. PMID: 31047376
Additionally, within-group analyses were conducted to determine whether the mean changes in BCVA and CRT at 52 weeks were associated positively or negatively with the baseline characteristics of interest. MAIN OUTCOME MEASURES: Consistency of treatment outcomes amon …
Additionally, within-group analyses were conducted to determine whether the mean changes in BCVA and CRT at 52 weeks were associated positiv …
Baseline patients' characteristics as predictors for therapeutic survival and response in patients with psoriasis on biological treatments.
Xie KK, Braue A, Martyres R, Varigos G. Xie KK, et al. Australas J Dermatol. 2018 Nov;59(4):e247-e252. doi: 10.1111/ajd.12760. Epub 2018 Jan 8. Australas J Dermatol. 2018. PMID: 29315464
We aimed to examine the association of baseline patients' characteristics with the short-term efficacy and the long-term survival of biological therapies in patients with moderate to severe psoriasis. ...We used regression modelling to assess the association between …
We aimed to examine the association of baseline patients' characteristics with the short-term efficacy and the long-term survi …
110,029 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "baseline characteristics"